Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiska Weisblum

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Cell|July 10, 2020
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodiesFrauke Muecksch, Yiska Weisblum, Christopher O Barnes, et al.
Gut Microbes|August 2, 2022
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infectionJulia A Brown, Katherine Z Sanidad, Serena Lucotti, et al.
Immunity|July 31, 2021
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutationsFrauke Muecksch, Yiska Weisblum, Christopher O Barnes, et al.
Science (New York, N.Y.)|October 14, 2021
Replication and single-cycle delivery of SARS-CoV-2 repliconsInna Ricardo-Lax, Joseph M Luna, Tran Thi Nhu Thao, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2Fred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Elife|December 7, 2021
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escapeFred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Nature|February 10, 2021
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsZijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsZijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cell|July 10, 2020
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodiesChristopher O Barnes, Anthony P West, Kathryn E Huey-Tubman, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodiesFrauke Muecksch, Yiska Weisblum, Christopher O Barnes, et al.
Gut Microbes|August 2, 2022
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infectionJulia A Brown, Katherine Z Sanidad, Serena Lucotti, et al.
Immunity|July 31, 2021
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutationsFrauke Muecksch, Yiska Weisblum, Christopher O Barnes, et al.
Science (New York, N.Y.)|October 14, 2021
Replication and single-cycle delivery of SARS-CoV-2 repliconsInna Ricardo-Lax, Joseph M Luna, Tran Thi Nhu Thao, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2Fred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Elife|December 7, 2021
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escapeFred D Mast, Peter C Fridy, Natalia E Ketaren, et al.
Nature|February 10, 2021
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsZijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsZijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Pageof 5